HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus

KA Lurain, R Ramaswami, LT Krug… - Clinical Microbiology …, 2024 - journals.asm.org
Within weeks of the first report of acquired immunodeficiency syndrome (AIDS) in 1981, it
was observed that these patients often had Kaposi sarcoma (KS), a hitherto rarely seen skin …

[HTML][HTML] Epidemiology of Kaposi's sarcoma in sub-Saharan Africa

M Motlhale, F Sitas, D Bradshaw, WC Chen… - Cancer …, 2022 - Elsevier
Kaposi's sarcoma (KS) has become a common AIDS-defining cancer in sub-Saharan Africa.
Kaposi's sarcoma-associated human herpesvirus strongly modulated by HIV-related …

Global patterns and trends in Kaposi sarcoma incidence: a population-based study

L Fu, T Tian, B Wang, Z Lu, Y Gao, Y Sun… - The Lancet Global …, 2023 - thelancet.com
Background Kaposi sarcoma is a rare, possibly angioproliferative, tumour. Kaposi sarcoma
is one of the most common cancers in people living with HIV and poses a serious public …

Oncologic treatment of HIV-associated Kaposi sarcoma 40 years on

R Ramaswami, K Lurain, R Yarchoan - Journal of Clinical Oncology, 2022 - ascopubs.org
The observation in 1981 of the emergence of Kaposi sarcoma (KS) among young men who
had sex with men was one of the first harbingers of the HIV epidemic. With advances in HIV …

Skin cancer in people of color: a systematic review

GA Zakhem, AN Pulavarty, JC Lester… - American journal of …, 2022 - Springer
Abstract Background People of African, Asian, Hispanic or Latino, Pacific Islander, and
Native Indian descent are considered people of color by the Skin of Color Society (SOCS) …

Kaposi sarcoma rates among persons living with human immunodeficiency virus in the United States: 2008—2016

Q Luo, A Satcher Johnson, HI Hall… - Clinical Infectious …, 2021 - academic.oup.com
Background Recent studies have suggested that Kaposi sarcoma (KS) rates might be
increasing in some racial/ethnic groups, age groups, and US regions. We estimated recent …

Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma

K Lurain, R Ramaswami, I Ekwede, V Eulo… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE Cancer Immunotherapy Trials Network 12 demonstrated safety of
pembrolizumab in treating advanced cancer in people with HIV. Here, we report results of …

Kaposi sarcoma incidence, burden, and prevalence in United States people with HIV, 2000–2015

S Peprah, EA Engels, MJ Horner, A Monterosso… - … Biomarkers & Prevention, 2021 - AACR
Background: The introduction of combination antiretroviral therapy (cART) has led to a
significant reduction in Kaposi sarcoma (KS) incidence among people with HIV (PWH) …

Prevalence, Incidence, and Predictors of Kaposi Sarcoma–Associated Herpesvirus Infection Among Young Men Who Have Sex With Men in the Southern United …

M Salyards, AE Nijhawan, J Kuo… - The Journal of …, 2024 - academic.oup.com
Kaposi sarcoma (KS) continues to cause substantial morbidity and mortality in populations
at risk in the southern United States. Utilizing biospecimens from the Houston site of the …

Incidence trends of Kaposi sarcoma among young non-Hispanic black men by US regions, 2001-2018

R Suk, DL White, S Knights, A Nijhawan… - JNCI Cancer …, 2022 - academic.oup.com
Despite the overall national decline in Kaposi sarcoma (KS) incidence in the United States
among persons living with HIV, previous studies suggest there might be specific subgroups …